Home » Topics » Regulatory » Patents

Patents
RSS

New Toll-like receptor 9 antagonists identified at Bristol Myers Squibb

March 16, 2022

Alterity Therapeutics describes zinc and/or iron ionophores

March 16, 2022

Cybin IRL describes new 5-HT2 receptor agonists

March 15, 2022

Novel antibacterials synthesized at the University of Jordan

March 15, 2022

New psilocin prodrugs discovered at Compass Pathfinder

March 15, 2022

Council of Scientific and Industrial Research patents nigericin derivatives

March 15, 2022

1st Bio Therapeutics identifies new ABL/LRRK2/LRRK2 mutant/RIPK2 inhibitors

March 15, 2022

Medshine Discovery identifies new cyclin/CDK inhibitors

March 14, 2022

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Nav1.8 channel blockers

March 14, 2022

Chengdu Fanxi Biopharma discovers thyroid hormone receptor alpha/beta agonists

March 14, 2022

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...